Insider buying
~$30K20K sh @ $1.50
Traded May 8, 2025 · filed 4 days later
A Maia Biotechnology director paid $30K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 3, 2025 · Filed Jun 5, 2025
A Maia Biotechnology director paid $50K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$50,000
Shares × reported transaction price
$25K–$100K
+2.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 7 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.4% | −0.4% | −4.1% |
| 30 days | +1.7% | +3.6% | −1.9% |
| 90 days | −17.2% | +8.3% | −25.6% |
| 180 days | −37.8% | +14.2% | −51.9% |
| 365 days | −29.4% | +23.4% | −52.8% |
Past results only. Not a forecast.
Insider buying
Traded May 8, 2025 · filed 4 days later
A Maia Biotechnology director paid $30K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Insider buying
Traded May 8, 2025 · filed 4 days later
A Maia Biotechnology director paid $100K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 6% with this purchase.
Stan Smith, Director's past purchases, 90 days after disclosure: 11 buys, median −10.1 pts vs S&P 500, beat it 4 of 11 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.